Delivery Order SPE2DB22D1106-SPE2DB25FEUD9

Award Date 6/19/25
Potential Completion Date 6/20/25
Potential Value $2.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $24,354.70 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ALVIMOPAN 12 MG CAPSULE UD 30S, a medical product, and has an ultimate completion date of December 31, 2024. The contract is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a larger $999,999,999 Indefinite Delivery...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $19,498.96 award is for the supply of ALVIMOPAN 12 MG CAPSULE UD 30S, a medical product, with a period of performance through June 7, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $19,979.49 firm fixed price delivery order is for the supply of 4,566,047,909 units of the medication Alvimopan 12 MG Capsule UD 30S. The contract has an ultimate completion date of October 9, 2024. Amerisourcebergen holds significant Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical and the Department of Justice Federal Bureau...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, through its Corporate Office division in Conshohocken, Pennsylvania, to provide ALVIMOPAN 12 MG CAPSULE UD 30S. The contract has a potential value of $4,937.71 and a completion date of January 30, 2024. This delivery order is issued under an indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a for-profit pharmaceutical distribution company, for the supply of Alvimopan 12 mg capsules. The delivery order has a ceiling value of $24,037.80 and a period of performance through March 26, 2024. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $8,496.73 firm fixed price delivery order is for the supply of the pharmaceutical product Alvimopan 12 mg capsules, with a period of performance through April 2, 2024. Amerisourcebergen Drug Corp has an existing indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Alvimopan 12 mg capsules and has a ceiling value of $9,615.12. It is a firm-fixed-price delivery order with a period of performance through May 14, 2025. The contract is not set aside for any specific business category. Amerisourcebergen Drug Corp holds a significant Indefinite...
The Defense Logistics Agency awarded a $4,937.71 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a for-profit global pharmaceutical distribution company. The order is for the supply of Alvimopan 12 mg capsules and has a completion date of February 14, 2024. This delivery order is issued under an indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of the pharmaceutical product alvimopan 12 mg capsule in a 30-count unit dose package. The contract ceiling value is $13,216.88 and the ultimate completion date is April 19, 2024. This order is placed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division. The $2,080.46 firm fixed-price delivery order is for the provision of 4,564,898,629 units of the prescription medication Alvimopan 12 mg capsules. The award does not include a set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB25FEUD9
    Delivery Order

This is a firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $2,492.62 contract is for the supply of ALVIMOPAN 12 MG CAPSULE UD 30S, a medication. The contract has an ultimate completion date of June 20, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This delivery order is not designated as a set-aside contract.

Generated 9/18/25, 10:52 AM